by University Hospitals Cleveland Medical Center Reduced tumor sizes by FDG-PET imaging reflected in the red signal next to yellow arrows, in 6 mice receiving ivosidenib (AG-120) compared to control mice without drug. Credit: University Hospitals A drug used to target IDH1 mutations in select cancers also appears to inhibit the wild-type form of the enzyme,...
